As a leader in data-driven medicine, SOPHiA GENETICS lends its expertise to support White House Cancer Moonshot
SOPHiA GENETICS Announces Nomination of Lila Tretikov to Board of Directors
Microsoft’s Deputy Chief Technology Officer to be appointed at Annual Shareholders’ Meeting BOSTON...
SOPHiA GENETICS to Attend ASCO Annual Meeting
SOPHiA GENETICS leaders will talk onsite about the company’s cutting-edge SOPHiA DDM™ Platform
Institute of Oncology Ljubljana Leverages SOPHiA DDM ™ Platform for Cancer Research
SOPHiA DDMTM deep-learnings algorithm will help determine HRD status of tumors for Institute of Oncology Ljubljana researchers
Natural State Laboratories Chooses SOPHiA GENETICS to Help Launch their In-House Hereditary Cancer Testing
SOPHiA GENETICS technology will help increase cancer research abilities
Dasa Expands Its Capabilities with SOPHiA GENETICS
In just one year of using SOPHiA DDM™ HRD, Dasa reaches 2,000 samples analyzed BOSTON and...
SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2023
Strong growth momentum and efficient expense execution continues
SOPHiA GENETICS’ SOPHiA DDM™ HRD Solution is tapped by Unipath Specialty Laboratory Limited
SOPHiA GENETICS expands footprint in India as Unipath Specialty Laboratory Limited is now live on SOPHiA DDM™ HRD Solution
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2023 on May 9, 2023
BOSTON and GENEVA, Switzerland, April 25, 2023 (GLOBE NEWSWIRE) — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the first quarter of fiscal 2023 before U.S. markets open on Tuesday, May 9, 2023. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CEST.
SOPHiA GENETICS Celebrates Swiss Biotech Award
Recognition by the Swiss Biotech Association for SOPHiA GENETICS’ Outstanding Contributions as a Leader in Data-Driven Medicine
The University of Maryland Medical Center Chooses SOPHiA GENETICS Technology
SOPHiA GENETICS supports The University of Maryland Medical Center to advance their rare...
Krsnaa Diagnostics is Live on SOPHiA GENETICS
SOPHiA DDM™ for Hereditary Cancers Enables Krsnaa Diagnostics to Expand its NGS Offerings...